Invest in Oatmeal Health

Lung cancer takes more lives than breast, colon, and prostate combined.

It's the one major cancer that never got its screening moment. We're building it. Mammograms made breast cancer survivable. Colonoscopies, colon cancer. We're doing the same for lung.

"I lost both my grandparents to lung cancer and more than ten other family members to other cancers and chronic disease. I'm building Oatmeal so fewer families have to go through that."

Jonathan Govette · Co-Founder & CEO

We've built more than the moment suggests: signed distribution across 20+ US health systems, a reimbursement code that already exists, and a validated AI model, all on $1.27M raised, including $675K of non-dilutive grants from Google and Lung Cancer Foundation of America. Comparable companies were valued at $70-90M before FDA clearance, with less distribution than we have today.

This page is for informational purposes only and does not constitute an offer to sell, or the solicitation of an offer to buy, any securities. Any offer or sale of securities will be made only to accredited investors (as defined in Rule 501 of Regulation D under the Securities Act of 1933) and solely pursuant to definitive transaction documents, including a subscription agreement and a Simple Agreement for Future Equity (SAFE). Oatmeal Health will take reasonable steps to verify accredited-investor status prior to accepting any investment, consistent with Rule 506(c). Forward-looking statements, including contracted revenue figures, pipeline estimates, and projected timelines, involve risks and uncertainties; actual results may differ materially. Contracted revenue activities are contingent on FDA 510(k) clearance, which has not yet been obtained. Past performance and comparable-company outcomes are not indicative of future results.

Software as a Medical Device is one of the fastest-growing categories in healthcare with lung cancer leading the charge.

We’ve had more investor interest than we can accommodate with individual meetings, so we’re raising in the open. Tell us the valuation and terms you’d invest in below. Accredited investors who submit get the full pitch and data room. No one else sees your number; we’re letting the market set the price.